Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ABBV AbbVie | ABT Abbott Laboratories |
|---|---|---|
| Price | $263.96 -0.0% | $102.61 +0.4% |
| StockIQ Score | 59C Moderate Risk: High | 51C- Moderate Risk: Medium |
| Technical | 88A | 19F |
| Fundamental | 57C | 72B |
| Growth | 34F | 45D+ |
| Fair Value | 33F | 38F |
| News | 100A+ | 100A+ |
| Quality | 42D | 63C+ |
| Risk | 36F | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Abbott Laboratories (ABT) outperforms AbbVie (ABBV) in fundamentals, scoring 72 compared to 56. ABBV leads in technicals with a 58 versus ABT’s 50. Both share a "MODERATE" rating, but ABT’s higher fundamental score suggests stronger financial health, while ABBV’s technical score hints at better short-term market trends.